Whalesbook
Q4 Profits Jump Amid Stronger Underwriting
Star Health Insurance's fourth-quarter results revealed a sharp rise in net profit to ₹111 crore, a significant turnaround from ₹51 lakh recorded in the prior year's comparable period. This strong performance was primarily fueled by a 16% year-on-year surge in gross written premium (GWP) to ₹5,968 crore and a 14% increase in net earned premium to ₹4,327 crore. The company also achieved a significant operational improvement, posting a profit of ₹64 crore against a loss of ₹87 crore in the previous year. Chief Financial Officer Nilesh Kambli attributed this improved profitability to better performance in retail loss ratios, cutting back on unprofitable group insurance portfolios, and tighter underwriting practices, particularly for portability business. Targeted price increases, especially in the bank indemnity segment, helped reduce the group loss ratio by 12%. The overall loss ratio for FY26 improved by 194 basis points to 68.7%, with the retail loss ratio declining by 97 basis points to 68.2%. Under the Ind-AS accounting framework, adopted from April 1, 2026, profit after tax for FY26 stood at ₹911 crore, up from ₹787 crore in FY25. This transition provides a clearer view of underlying operational profitability compared to less stable Indian GAAP reporting.
Revised Growth Targets Signal Focus on Profit
Despite the robust growth in GWP for FY26, reaching ₹20,369 crore, Star Health has revised its long-term growth targets. The company has lowered its Gross Written Premium target for FY28 to ₹27,500 crore from an earlier projection of ₹30,000 crore. This adjustment reflects a reduced focus on the less profitable group insurance segment, showing a greater focus on profitability and sustainability rather than just market share growth. This shift aligns with a wider industry trend moving from a volume-first approach to one focused more on customer needs and long-term engagement.
Star Health's Valuation vs. Peers in a Growing Market
Star Health Insurance trades at a Price-to-Earnings (P/E) ratio of about 67.6x. This P/E is significantly higher than its listed peers, such as ICICI Lombard General Insurance, which trades at a P/E around 31.88x, and SBI General Insurance, an unlisted entity with an estimated P/E of 90.15x. The company's market capitalization stands at roughly ₹30,317 crore. India's health insurance market is set for strong growth, expected to grow from about USD 16 billion in 2025 to over USD 39 billion by 2032, driven by rising healthcare costs, greater health awareness after the pandemic, and government initiatives such as Ayushman Bharat. Star Health, as a leading standalone health insurer, operates in this growing, competitive sector. Analysts have a consensus 'Buy' rating, with an average 12-month price target of ₹528.14, suggesting about 3.02% upside. The stock is up 29.58% over the past year, trading near its 52-week high of ₹534.00.
Challenges: High Valuation and Regulatory Shifts
Despite the improved profitability and strategic adjustments, Star Health faces significant challenges. Its high valuation, evidenced by the P/E ratio, means future earnings growth must be strong to meet investor expectations. The strategic decision to reduce focus on group insurance and prioritize profitability over volume, though sensible, could slow market share growth, as competitors expand aggressively. Additionally, the health insurance sector faces changing regulations, including IRDAI's push for faster cashless claims settlement and possible changes to premium pricing or cost structures. While the Ind-AS transition should offer a clearer and more consistent view of Star Health's financial performance, potentially boosting reported return ratios, it also highlights the complex relationship between accounting standards and reported profits. The company received a ₹3.39 crore penalty for cybersecurity lapses, highlighting potential governance and operational risks.
Outlook: Balancing Growth and Profitability
The adoption of Ind-AS accounting from April 1, 2026, should offer a clearer and more consistent view of Star Health's financial performance, potentially boosting reported return ratios. Analysts anticipate continued growth for the company, as the Indian health insurance market grows. However, investors will watch closely Star Health's ability to maintain underwriting discipline, manage costs, and handle competition while meeting profit targets. The revised GWP guidance indicates management's commitment to a more balanced growth approach.